Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Cash from Operations (2016 - 2025)

Anaptysbio's Cash from Operations history spans 10 years, with the latest figure at 97997000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 246.98% year-over-year to 97997000.0; the TTM value through Dec 2025 reached 19697000.0, up 114.55%, while the annual FY2025 figure was 19697000.0, 114.55% up from the prior year.
  • Cash from Operations reached 97997000.0 in Q4 2025 per ANAB's latest filing, up from 27356000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 97997000.0 in Q4 2025 to a low of 66672000.0 in Q4 2024.
  • Average Cash from Operations over 5 years is 17797650.0, with a median of 23675500.0 recorded in 2021.
  • Peak YoY movement for Cash from Operations: plummeted 351.77% in 2022, then surged 246.98% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 25301000.0 in 2021, then surged by 57.77% to 10685000.0 in 2022, then tumbled by 221.47% to 34349000.0 in 2023, then tumbled by 94.1% to 66672000.0 in 2024, then soared by 246.98% to 97997000.0 in 2025.
  • Per Business Quant, the three most recent readings for ANAB's Cash from Operations are 97997000.0 (Q4 2025), 27356000.0 (Q3 2025), and 40244000.0 (Q2 2025).